Pathology quiz case 2

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 4, 2003, Pages

  Williamson, Genevieve ^a   Rao, Uma ^a   Myers, Eugene N ^a   Hunt, Jennifer L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53;

AGED; ANAMNESIS; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GENE THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHYSICAL EXAMINATION; THYROID CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 0037386284     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.4.486     Document Type: Article

References (6)

1. Khoo M, Freeman J. Undifferentiated thyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2000;8:113-116.
2. McIver B, Hay I, Giuffrida D, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001;130:1028-1034.
3. Giuffrida D, Gharib H. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol. 2000;11:1083-1089.
4. Pierie J, Muzikansky A, Gaz R, Faquin WC, Ott MJ. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol. 2001;9:57-64.
5. Filie AC, Chiesa A, Bryant BR, Merino MJ, Sobel ME, Abati A. The tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms. Cancer. 1999;87:238-242.
6. Nagayama Y, Yokoi H, Takeda K, et al. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo. J Clin Endocrinol Metab. 2000;85:4081-4086.